
Experts discuss the complexities of MS progression, exploring traditional phenotypes and the evolving understanding of the disease as a continuum.

Experts discuss the complexities of MS progression, exploring traditional phenotypes and the evolving understanding of the disease as a continuum.

Experts discuss the complexities of MS progression, exploring traditional phenotypes and the evolving understanding of the disease as a continuum.

The director and founder of The MS Center for Innovations in Care provided thoughts on the potential role of biosimilars in treating multiple sclerosis and the steps needed to ensure that this integration process is safe. [WATCH TIME: 4 minutes]